Séverine Tabone‐Eglinger

950 total citations
28 papers, 446 citations indexed

About

Séverine Tabone‐Eglinger is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Séverine Tabone‐Eglinger has authored 28 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Gastroenterology and 6 papers in Surgery. Recurrent topics in Séverine Tabone‐Eglinger's work include Gastrointestinal Tumor Research and Treatment (11 papers), Gastrointestinal disorders and treatments (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Séverine Tabone‐Eglinger is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (11 papers), Gastrointestinal disorders and treatments (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Séverine Tabone‐Eglinger collaborates with scholars based in France, Switzerland and United States. Séverine Tabone‐Eglinger's co-authors include Antoinette Lemoine, Jean‐François Emile, Jean‐Yves Blay, Frédéric Subra, Anne Lavergne‐Slove, Philippe Terrier, Laurent Alberti, Catherine Julié, Nathalie Théou–Anton and Bernhard Wehrle‐Haller and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Séverine Tabone‐Eglinger

26 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Séverine Tabone‐Eglinger France 12 209 194 109 99 83 28 446
Mirjam F. Mastik Netherlands 14 283 1.4× 170 0.9× 119 1.1× 38 0.4× 175 2.1× 28 656
Maria Stefania Lagonigro Italy 10 382 1.8× 319 1.6× 187 1.7× 32 0.3× 65 0.8× 13 679
Hiroyuki Hiraki Japan 10 171 0.8× 80 0.4× 68 0.6× 47 0.5× 97 1.2× 15 372
Craig A. Rumpel United States 8 132 0.6× 132 0.7× 196 1.8× 23 0.2× 125 1.5× 8 425
Yoshinao Oda Japan 14 320 1.5× 86 0.4× 164 1.5× 56 0.6× 281 3.4× 21 734
Mercedes M. Condy United States 8 328 1.6× 61 0.3× 26 0.2× 40 0.4× 252 3.0× 15 456
Joana Vieira Portugal 14 293 1.4× 44 0.2× 85 0.8× 29 0.3× 220 2.7× 39 701
J.C. Vaillant France 7 92 0.4× 106 0.5× 128 1.2× 178 1.8× 279 3.4× 15 622
T. R. J. Evans United Kingdom 11 87 0.4× 25 0.1× 106 1.0× 44 0.4× 134 1.6× 25 467
Javier García del Muro Spain 10 554 2.7× 435 2.2× 267 2.4× 41 0.4× 229 2.8× 19 939

Countries citing papers authored by Séverine Tabone‐Eglinger

Since Specialization
Citations

This map shows the geographic impact of Séverine Tabone‐Eglinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Tabone‐Eglinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Tabone‐Eglinger more than expected).

Fields of papers citing papers by Séverine Tabone‐Eglinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Tabone‐Eglinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Tabone‐Eglinger. The network helps show where Séverine Tabone‐Eglinger may publish in the future.

Co-authorship network of co-authors of Séverine Tabone‐Eglinger

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Tabone‐Eglinger. A scholar is included among the top collaborators of Séverine Tabone‐Eglinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Tabone‐Eglinger. Séverine Tabone‐Eglinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitte, Anne-Laure, Florent Chuffart, Emmanuelle Jacquet, et al.. (2025). Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach. NAR Cancer. 7(2). zcaf020–zcaf020.
2.
Dupuy, Marie, et al.. (2025). Modelling hepatocellular carcinoma microenvironment phenotype to evaluate drug efficacy. Scientific Reports. 15(1). 1179–1179. 1 indexed citations
3.
Dufresne, Armelle, Valéry Attignon, Anthony Ferrari, et al.. (2024). Added value of whole‐exome and RNA sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. Cancer Medicine. 13(7). e7115–e7115. 1 indexed citations
4.
Tabone‐Eglinger, Séverine, Didier Surdez, Olivier Delattre, et al.. (2022). Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement. European Journal of Cancer. 179. 56–64. 7 indexed citations
5.
Paternot, Sabine, Eric Raspé, Maxime Tarabichi, et al.. (2022). Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4 /6 inhibition. Molecular Oncology. 18(4). 866–894. 6 indexed citations
6.
7.
Fraunhoffer, Nicolás A., Abdessamad El-Kaoutari, Odile Gayet, et al.. (2021). Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models. Cancers. 13(10). 2473–2473. 8 indexed citations
8.
Pissaloux, Daniel, Laurent Alberti, Séverine Tabone‐Eglinger, et al.. (2013). Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas. Targeted Oncology. 8(4). 261–269. 9 indexed citations
9.
10.
Pradier, Amandine, Séverine Tabone‐Eglinger, Vincent J. Huber, et al.. (2013). Peripheral blood CD56brightNK cells respond to stem cell factor and adhere to its membrane‐bound form after upregulation of c‐kit. European Journal of Immunology. 44(2). 511–520. 9 indexed citations
11.
Bachet, Jean‐Baptiste, Séverine Tabone‐Eglinger, Frédéric Subra, et al.. (2012). Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild‐type and mutant forms of KIT. Molecular Oncology. 7(3). 323–333. 9 indexed citations
12.
Bachet, Jean‐Baptiste, Isabelle Hostein, Axel Le Cesne, et al.. (2009). Prognosis and predictive value of KIT exon 11 deletion in GISTs. British Journal of Cancer. 101(1). 7–11. 36 indexed citations
13.
Cassier, Philippe A., Armelle Dufresne, Samia Arifi, et al.. (2008). Imatinib mesilate for the treatment of gastrointestinal stromal tumour. Expert Opinion on Pharmacotherapy. 9(7). 1211–1222. 17 indexed citations
14.
Tabone‐Eglinger, Séverine, Frédéric Subra, Laurent Alberti, et al.. (2008). KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 14(8). 2285–2294. 62 indexed citations
15.
Arifi, Samia, Armelle Dufresne, Isabelle Ray‐Coquard, et al.. (2008). [Imatinib and solid tumours].. PubMed. 95(1). 99–106. 4 indexed citations
16.
Fayette, Jérôme, Pierre Méeus, Isabelle Ray‐Coquard, et al.. (2006). Traitement médical des tumeurs stromales gastro-intestinales localisées et avancées : standards thérapeutiques en 2006. Bulletin du Cancer. 93(4). 173–180. 1 indexed citations
17.
Fayette, Jérôme, Emmanuelle Bompas, Séverine Tabone‐Eglinger, et al.. (2006). Aromatase inhibitors (AI) are highly effective in uterine sarcomas (US) expressing estrogen receptors. Journal of Clinical Oncology. 24(18_suppl). 9576–9576. 7 indexed citations
18.
Tabone‐Eglinger, Séverine, Agnieszka Woźniak, Raphaël Saffroy, et al.. (2005). KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1741(1-2). 165–172. 32 indexed citations
19.
Emile, Jean‐François, Séverine Tabone‐Eglinger, A. Cortez, et al.. (2004). Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors. Clinical Gastroenterology and Hepatology. 2(7). 597–605. 63 indexed citations
20.
Tabone‐Eglinger, Séverine, Raphaël Saffroy, Axel Le Cesne, et al.. (2004). High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1688(3). 250–256. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mirjam F. Mastik Breakdown of academic impact, for papers by Maria Stefania Lagonigro Breakdown of academic impact, for papers by Hiroyuki Hiraki Breakdown of academic impact, for papers by Craig A. Rumpel Breakdown of academic impact, for papers by Yoshinao Oda Breakdown of academic impact, for papers by Mercedes M. Condy Breakdown of academic impact, for papers by Joana Vieira Breakdown of academic impact, for papers by J.C. Vaillant Breakdown of academic impact, for papers by T. R. J. Evans Breakdown of academic impact, for papers by Javier García del Muro
Rankless by CCL
2026